News

< Back

AFAR in the News: Australian publication Cosmos spotlights the TAME Trial and age-targeting drugs


On August 14, 2017, the Australian publication Cosmos featured 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, 1994 AFAR Research Grant recipient, and AFAR Deputy Scientific Director Nir Barzilai, MD and 2007 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award winner Matt Kaeberlein, PhD.

The article, Going to trial: anti-ageing pills, details the AFAR-managed Targeting Aging with Metformin (TAME) trial and Dr. Kaeberlein’s Dog Aging Project.

Dr. Barzilai tells Cosmos: “If the trial ends up the way we except, that should be enough for the FDA to accept aging per se as a treatable indication.”

Read the full Cosmos article here.

Nir Barzilai, MD is the Director of the Institute for Aging Research and the Director of the Nathan Shock Centers of Excellence in the Biology of Aging at Albert Einstein College of Medicine.

Matt Kaeberlein, PhD is a Professor at the University of Washington School of Medicine and the Director of University of Washington Medicine Nathan Shock Center of Excellence in the Basic Biology of Aging.


For more information on TAME, please see our TAME FAQ page here.

To learn more about the Dog Aging Project, we encourage you to explore our summary of a related feature story in The New York Times here.

More Recent News

View All News >
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research.
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research.
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature.
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature.
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Norman Volk, Former AFAR Board Member
In Memoriam: Norman Volk, Former AFAR Board Member
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors